James Paul Lang Insider Trading $OPRX OptimizeRx Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James Paul Lang.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Paul Lang. James Paul Lang is Director in OptimizeRx Corp ($OPRX) and Director in BIOVIE INC. ($BIVI).
James Paul Lang in OptimizeRx Corp
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of James Paul Lang: Director
Holdings: 32,253 shares
Current Value: $23,867
Latest Transaction: Apr 02 2021
$OPRX Market Capitalization: $22.85M
$OPRX Previous Close: $0.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James Paul Lang in OptimizeRx Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 539 | 0 | 32,253 | 31.7 K to 32.3 K (+1.70 %) |
| Jan 20 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 802 | 0 | 31,714 | 30.9 K to 31.7 K (+2.59 %) |
| Jan 20 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 1,183 | 0 | 30,912 | 29.7 K to 30.9 K (+3.98 %) |
| Jul 02 2020 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 1,937 | 0 | 29,729 | 27.8 K to 29.7 K (+6.97 %) |
| Mar 31 2020 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,784 | 0 | 27,792 | 25 K to 27.8 K (+11.13 %) |
| Jan 07 2020 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 25,008 | 22.9 K to 25 K (+9.09 %) |
| Oct 02 2019 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 22,924 | 20.8 K to 22.9 K (+10.00 %) |
| Mar 29 2019 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 14,585 | 12.5 K to 14.6 K (+16.67 %) |
| Oct 12 2018 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 12,501 | 10.4 K to 12.5 K (+20.01 %) |
| Jul 03 2018 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 2,084 | 0 | 10,417 | 8.3 K to 10.4 K (+25.01 %) |
| Jan 12 2018 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 6,250 | 0 | 25,000 | 18.8 K to 25 K (+33.33 %) |
| Oct 02 2017 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 6,250 | 0 | 18,750 | 12.5 K to 18.8 K (+50.00 %) |
| Jun 30 2017 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 6,250 | 0 | 12,500 | 6.3 K to 12.5 K (+100.00 %) |
| Apr 06 2017 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
Page: 1